Sunmax Pharma Profile
Key Indicators
- Authorised Capital ₹ 4.00 M
- Paid Up Capital ₹ 4.00 M
- Company Age 21 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 10.75 Cr
- Satisfied Charges ₹ 6.62 Cr
- Revenue Growth -74.50%
- Profit Growth -113.92%
- Ebitda 4183.01%
- Net Worth -1.11%
- Total Assets -54.98%
About Sunmax Pharma
Sunmax Pharma Limited (SPL) is a Public Limited Indian Non-Government Company incorporated in India on 26 September 2003 and has a history of 21 years and four months. Its registered office is in Chandigarh, Chandigarh.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 4.00 M and a paid-up capital of Rs 4.00 M.
The company currently has active open charges totaling ₹10.75 Cr. The company has closed loans amounting to ₹6.62 Cr, as per Ministry of Corporate Affairs (MCA) records.
Ankit Agarwal, Aarohi Agarwal, and Rohan Agarwal serve as directors at the Company.
Company Details
- LocationChandigarh, Chandigarh
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media-
Corporate Identity Details
- CIN/LLPIN
U24230CH2003PLC026404
- Company No.
026404
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
26 Sep 2003
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chandigarh
Industry
Who are the key members and board of directors at Sunmax Pharma?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Aarohi Agarwal  | Director | 12-Nov-2018 | Current |
| Ankit Agarwal | Director | 01-Jan-2005 | Current |
| Rohan Agarwal | Director | 02-Apr-2011 | Current |
Financial Performance of Sunmax Pharma.
Sunmax Pharma Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 74.5% decrease. The company also saw a substantial fall in profitability, with a 113.92% decrease in profit. The company's net worth dipped by a decrease of 1.11%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sunmax Pharma?
In 2023, Sunmax Pharma had a promoter holding of 72.25% and a public holding of 27.75%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Bushwell Private LimitedAnkit Agarwal and Rohan Agarwal are mutual person
Actinova Private LimitedAnkit Agarwal and Rohan Agarwal are mutual person
Charges (Loans)
₹107.50 M
₹66.24 M
Charges Breakdown by Lending Institutions
- Others : 10.75 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 23 Mar 2018 | Others | ₹10.75 Cr | Open |
| 04 Aug 2007 | Union Bank Of India | ₹6.62 Cr | Satisfied |
How Many Employees Work at Sunmax Pharma?
Unlock and access historical data on people associated with Sunmax Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sunmax Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sunmax Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
